The c.423-11A>G variant in APC is an intronic variant which substitutes adenine with guanine at position -11 in intron 4. This variant has been reported in 3 probands meeting phenotypic criteria, resulting in a total phenotype score of 2 (PS4_Moderate, Ambry Genetics, Bonn internal data). RT-PCR of this APC variant in patients with FAP showed that it impacted splicing by leading to insertion of the last 10 bp of intron 4 (r.422_423ins423-10_423-1)(p.Ser142Lysfs*3)(PS3_Moderate; PMID21779980, Ambry Genetics, Bonn internal data). The results from 2 in silico splicing predictors indicate that this variant may affect splicing by disrupting the acceptor splice site of intron 4 of APC (PP3). Finally, this variant is absent from gnomAD v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Likely Pathogenic for FAP based on the ACMG/AMP criteria applied, as specified by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel: PS3_Moderate, PS4_Moderate, PP3 and PM2_supporting (VCEP specifications version 1; date of approval 12/12/2022).